Prestige Brands Holdings, Inc. — Form 10-Q Summary
Business context and reporting period
The filing is for the three months ended June 30, 2016, the first quarter of fiscal 2017. The company markets and distributes over-the-counter healthcare and household cleaning products in North America and selected international markets. The filing registrant is Prestige Brands Holdings, Inc.
Financial performance and position
| Metric | Q1 FY2017 | Prior-year quarter |
|---|---|---|
| Total revenue | $209.6 million | $192.1 million |
| Gross profit / margin | $121.6 million / 58.0% | $112.2 million / 58.4% |
| Operating income | $12.2 million | $62.5 million |
| Net income (loss) | $(5.5) million; $(0.10) per diluted share | $26.2 million; $0.49 per diluted share |
| Cash from operations | $50.8 million | $43.5 million |
- Revenue grew 9.1%, primarily reflecting DenTek, acquired in February 2016; DenTek contributed about $15.0 million of current-quarter revenue not present in the prior-year period.
- A $55.5 million pretax loss related to the sale of Pediacare, New Skin and Fiber Choice drove the reported operating and net losses. The sale loss was noncash in the quarter’s cash-flow reconciliation.
- Advertising and promotion was $27.6 million; general and administrative expense was $19.5 million; net interest expense was $21.1 million. The effective tax rate was 37.9%, and the company recorded a $3.4 million tax benefit.
- Cash and cash equivalents were $28.9 million at June 30, versus $27.2 million at March 31. Current assets were $281.4 million and current liabilities $100.1 million.
- Capital expenditures were $0.9 million. Financing cash outflow was $47.4 million, including $50.0 million of term-loan repayments.
- Debt principal was $1.603 billion, down from $1.653 billion at March 31; net debt after cash was approximately $1.574 billion. The company had $85.0 million drawn on its ABL revolver and $38.6 million of remaining borrowing capacity.
Material changes versus the prior comparable period
- North American OTC Healthcare revenue increased 10.6% and International OTC Healthcare revenue increased 11.0%, both largely supported by DenTek. Household Cleaning revenue declined 2.6%; its gross margin fell to 22.5% from 26.0%, which management attributed to channel declines and unfavorable product mix.
- Gross margin eased to 58.0% from 58.4%, reflecting unfavorable mix in North American OTC Healthcare and Household Cleaning. Operating income fell sharply because of the asset-sale loss.
- Operating cash flow rose $7.2 million year over year, despite the net loss, reflecting noncash adjustments that included the disposal loss.
Outlook, commentary, risks and unusual items
- Management said operating cash generation and existing credit facilities should be adequate for working capital and capital expenditures over the next 12 months, excluding acquisitions, while noting there is no assurance.
- The estimated effective tax rate for the remaining quarters of FY2017 is approximately 35.5%, excluding acquisitions and discrete items. No broader revenue or earnings guidance is provided in the supplied filing text.
- The sale of Pediacare, New Skin and Fiber Choice closed July 7, 2016, for approximately $40.1 million including inventory, less immaterial holdbacks; proceeds were used to repay debt. A transition-services arrangement runs through January 7, 2017, and the buyer has an option to purchase Dermoplast under specified terms.
- After quarter-end, the Comet licensee elected to acquire remaining license rights; the company expects quarterly royalty income to decline by approximately $0.8 million beginning in Q2 FY2017, when the transaction is expected to close.
- CFO David Marberger resigned effective August 5, 2016; CEO Ron Lombardi was to serve as interim CFO while the company searched for a replacement.
- The company reported compliance with applicable debt covenants at June 30. It noted variable-rate exposure: a 1 percentage-point interest-rate increase would have increased quarterly pretax expense by approximately $2.2 million, holding other factors constant.
- Key risks include substantial indebtedness, customer concentration (Walmart accounted for about 20.7% of gross revenue), dependence on third-party manufacturers and a principal distribution center, foreign-exchange exposure, and potential impairment of goodwill and intangible assets, which totaled $2.58 billion.
Important facts for investors to verify
- How much of revenue growth and future profitability is attributable to DenTek, and whether integration and acquisition costs persist.
- The final economics and cash proceeds from the divestiture, including holdbacks, transition-service costs and any Dermoplast option exercise.
- Debt reduction after applying sale proceeds, available revolving capacity, and continued covenant compliance.
- Whether Household Cleaning’s weaker revenue and margins improve, and whether mix or input-cost pressures continue.
- The timing and financial impact of the Comet royalty-rights transaction and resulting royalty decline.
- Whether goodwill and brand valuations remain supportable given sales trends, competition and the company’s high concentration of assets in goodwill and intangibles.